Mazin Abdelghany

5PUBLICATIONS
21CO-AUTHORS
Bioinformatic methods developmentEpidemiological modellingInfectious diseasesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 16, 2026
Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease.

|Jun 03, 2025
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death.

Allyson Mateja, Eric Chu, Thomas A Murray

|Feb 13, 2025
Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment.

Sean Regan, Rita Humeniuk, Luzelena Caro

|Jun 28, 2024
Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants.

Olena Anoshchenko, Mazin Abdelghany, Amos Lichtman

Pageof 1

Frequent Collaborators

2 joint publications

David R Boulware

2 joint publications

Gail E Potter

2 joint publications

Carlee Moser

2 joint publications

Robert H Hyland